111, Inc. Reports Q1 2026 Financial Results Highlighting Strategic Transition
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Source: PRnewswire
- Revenue Decline: In Q1 2026, net revenue amounted to RMB 2.4 billion (approximately $342.4 million), representing a 33.1% year-over-year decrease primarily due to strategic optimization, indicating challenges faced during the company's transition.
- Gross Margin Pressure: The gross profit for the quarter was RMB 126 million (about $18.3 million), reflecting a 35.4% year-over-year decline, highlighting the need for enhanced cost control to maintain competitiveness amid falling revenues.
- Fulfillment Cost Reduction: By optimizing its network and selectively exiting underperforming fulfillment centers, fulfillment expenses decreased by 34.6% year-over-year, demonstrating positive progress in operational efficiency that aids in improving overall financial health.
- Future Outlook: The company plans to continue integrating AI technologies to enhance operational efficiency; despite current losses, 111 aims to achieve sustainable growth and improve profitability through its intelligent transformation.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy YI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on YI
About YI
111 Inc is an investment holding company primarily engaged in the operation of integrated online and offline healthcare platform. The Company mainly operates its business through two segments. The Business to Customer (B2C) segment is engaged in the sale of pharmaceutical and other health and wellness products through 1 Medicine Marketplace, mobile apps, other online channels and offline pharmacies to consumers and certain enterprise customers. The Business to Business (B2B) segment is engaged in the sale of pharmaceutical products to pharmacies on 1 Pharmacy. The Company also provides customers with online consultation and electronic prescription services through the Internet hospital 1 Clinic. The Company’s products include drugs, nutritional supplements, medical supplies and devices and other products. The Company mainly conducts its business in the domestic market.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Financial Overview: 111 reported a non-GAAP EPS of -$0.60 for Q1 2026, indicating significant challenges to profitability in the current economic environment, which is likely to negatively impact investor confidence.
- Revenue Decline: The company recorded revenue of $342.36 million, a 33.1% year-over-year decrease, reflecting a significant drop in sales performance amid intensified market competition and weak consumer demand, potentially affecting future market share.
- Cash Flow Position: As of March 31, 2026, 111 held cash and cash equivalents, restricted cash, and short-term investments totaling RMB 396.6 million (approximately $57.5 million), indicating a buffer in liquidity management, though future investments and operations may be constrained.
- Historical Financial Data: The historical earnings data provided by 111 will offer analysts and investors deeper insights to assess the company's performance and recovery potential in the current economic climate.
See More
- Revenue Decline: In Q1 2026, net revenue amounted to RMB 2.4 billion (approximately $342.4 million), representing a 33.1% year-over-year decrease primarily due to strategic optimization, indicating challenges faced during the company's transition.
- Gross Margin Pressure: The gross profit for the quarter was RMB 126 million (about $18.3 million), reflecting a 35.4% year-over-year decline, highlighting the need for enhanced cost control to maintain competitiveness amid falling revenues.
- Fulfillment Cost Reduction: By optimizing its network and selectively exiting underperforming fulfillment centers, fulfillment expenses decreased by 34.6% year-over-year, demonstrating positive progress in operational efficiency that aids in improving overall financial health.
- Future Outlook: The company plans to continue integrating AI technologies to enhance operational efficiency; despite current losses, 111 aims to achieve sustainable growth and improve profitability through its intelligent transformation.
See More
- Revenue Decline: In Q1 2026, net revenue was RMB 2.4 billion (approximately $342.4 million), representing a 33.1% decrease from RMB 3.5 billion in the same quarter last year, primarily due to the company's strategic transition towards a more asset-light and operationally efficient business model, impacting overall revenue performance.
- Marketplace Service Revenue Growth: Despite the decline in total revenue, marketplace service revenue increased by 24.7% year-over-year, indicating sustained growth in the company's marketplace service business and enhanced revenue quality, reflecting initial success of the strategic transition.
- Strong Promotional Product Performance: Net revenue from promotional products reached RMB 28.9 million, a 70.2% year-over-year increase, with gross profit rising by 75.0%, highlighting the company's strengthened capabilities in brand building and market penetration, particularly with
See More
- Narrowed Net Loss: 111, Inc. reported a net loss attributable to ordinary shareholders of RMB 16.22 million (RMB 1.80 per ADS) for Q4, an improvement from RMB 19.84 million (RMB 2.20 per ADS) in the same quarter last year, indicating effective cost control measures.
- Improved Operating Profit: The adjusted profit from operations was RMB 0.223 million (approximately $0.032 million), contrasting with a loss of RMB 2.292 million a year earlier, showcasing significant progress in operational efficiency despite declining revenues.
- Decreased Operating Costs: Operating costs and expenses for the fourth quarter were RMB 2.82 billion (approximately $403.32 million), a 26.8% decrease from last year, supporting the narrowed net loss and demonstrating successful cost management strategies.
- Revenue Decline: Quarterly net revenues fell to RMB 2.82 billion (approximately $403.28 million) from RMB 3.85 billion a year prior, reflecting market challenges and revenue pressures faced by the company.
See More
- Strategic Optimization Impact: 111, Inc. successfully transitioned to a warehouse partnership model by divesting 100% equity interests in several subsidiaries, which, while temporarily impacting revenue, has strengthened profitability and liquidity, positioning the company for sustained future growth.
- Revenue and Profit Changes: In Q4 2025, net revenues were RMB 2.8 billion, a 26.7% decrease year-over-year; however, non-GAAP operating profit turned positive, demonstrating the company's success in optimizing its operational structure.
- Sales Growth: Revenue from promotional products surged 76.2% year-over-year, with flagship product
See More
- Financial Highlights: 111 reported a Q4 Non-GAAP EPS of -$0.20, indicating significant profitability challenges, with a year-over-year decline of 26.7% reflecting ongoing operational difficulties.
- Revenue Decline: The company's revenue for Q4 was $403.28 million, down 26.7% year-over-year, suggesting weak market demand that could adversely affect future growth prospects.
- Cash Flow Status: Net cash provided by operating activities was RMB 29.9 million (approximately $4.3 million), indicating positive cash flow but also revealing cash flow pressures compared to previous performance, which may impact liquidity management.
- Future Outlook: Given the current economic environment, 111 must implement effective strategies to reverse the revenue decline trend to restore investor confidence and ensure sustainable growth.
See More









